Additional information
| Active substance | Testosterone Base |
|---|---|
| Dosage | 50 Mg |
| Water Retention | Negligible |
| Hepatotoxicity | Low |
| Lab Test | May interfere with tests for glucose in urine using copper reduction methods (Benedict’s or Fehling’s solution) |
| Also known as | Ceftriaxone sodium |
| Blood pressure | Little to no effect on blood pressure |
| Trade name | Rocephin |
| FORM | Injection |
| Milliliter Size | 10 Ml |
| Dosage Unit | Ml |
| ean13 | 1393923262228 |
| Reference | ALZNE21 |
| Storage conditions | Store vials at room temperature, away from light and moisture |
| Chemical name | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Formula | C18H18N8O7S3 |
| Substance class | Cephalosporin antibiotic |
| Main action | Bactericidal |
| Half-life | 6-9 hours |
| Dosage (medical) | Typically 1-2 grams per day, administered intravenously or intramuscularly, depending on the type and severity of the infection |
| Dosage (sports) | Not applicable |
| Effects | Effective against a wide range of gram-positive and gram-negative bacteria |
| Side effects | Allergic reactions, gastrointestinal disturbances like diarrhea, potential superinfection |
| Use in sports | Not typically used in sports |
| Packing | Vial |
Reviews
There are no reviews yet.